EGFR mutation and lobar location of lung adenocarcinoma

Chien Hua Tseng, Kun Chieh Chen, Kuo Hsuan Hsu, Jeng Sen Tseng, Chao Chi Ho, Te Chun Hsia, Kang Yi Su, Ming Fang Wu, Kuo Liang Chiu, Chien Ming Liu, Tzu Chin Wu, Hung Jen Chen, Hsuan Yu Chen, Chi Sheng Chang, Chung Ping Hsu, Jiun Yi Hsia, Cheng Yen Chuang, Chin Hung Lin, Jeremy J.W. Chen, Kuan Yu ChenWei Yu Liao, Jin Yuan Shih, Sung Liang Yu, Chong Jen Yu, Pan Chyr Yang, Tsung Ying Yang, Gee Chen Chang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The objective of this study was to investigate the associations among lung cancer location, and epidermal growth factor receptor (EGFR) mutation status. Treatment-naive, pathologically confirmed lung adenocarcinomas with tumor specimens available for genetic analysis were included from 2011 through 2014. Overall, 1771 patients with lung adenocarcinoma were included for analysis, after excluding those with carcinoma not otherwise specified, or synchronous multiple primary lung cancers. The median age was 64 years, and the female:male and never smoker:ever smoker ratios were 930:855 (52:48%) and 1167:604 (65:35%), respectively. The EGFR mutation rate was 56%. Among patients, 1093 (62%) had primary tumors in the upper lobes. Compared with the characteristics of the EGFR wild-type, tumors with EGFR activating mutations were more common in women (P < 0.001), never smokers (P < 0.001), and in the upper lobes (P = 0.004). Among EGFR activating mutations, compared with the EGFR exon 19 deletion, L858R mutation were more common in women (P = 0.002), never smokers (P = 0.038), and the upper lobes P < 0.0005). The present study is the first to address that different pulmonary lobar locations might harbor different EGFR mutation subtypes. We demonstrated that adenocarcinomas with L858R mutation, rather than exon 19 deletion or wild-type EGFR gene, prefer to locate over the upper lungs. This phenomenon was more significant in females and never-smokers, implying the result of complex interactions between genetic susceptibility and environmental factors. Therefore, EGFR L858R mutation and exon 19 deletion may not be identical disease entity from the point of carcinogenesis.

Original languageEnglish
Pages (from-to)157-162
Number of pages6
JournalCarcinogenesis
Volume37
Issue number2
DOIs
Publication statusPublished - Sep 8 2015

Fingerprint

Epidermal Growth Factor Receptor
Mutation
Exons
Lung Neoplasms
erbB-1 Genes
Neoplasms
Lung
Adenocarcinoma of lung
Sequence Deletion
Mutation Rate
Genetic Predisposition to Disease
Carcinogenesis
Adenocarcinoma
Carcinoma

ASJC Scopus subject areas

  • Cancer Research

Cite this

Tseng, C. H., Chen, K. C., Hsu, K. H., Tseng, J. S., Ho, C. C., Hsia, T. C., ... Chang, G. C. (2015). EGFR mutation and lobar location of lung adenocarcinoma. Carcinogenesis, 37(2), 157-162. https://doi.org/10.1093/carcin/bgv168

EGFR mutation and lobar location of lung adenocarcinoma. / Tseng, Chien Hua; Chen, Kun Chieh; Hsu, Kuo Hsuan; Tseng, Jeng Sen; Ho, Chao Chi; Hsia, Te Chun; Su, Kang Yi; Wu, Ming Fang; Chiu, Kuo Liang; Liu, Chien Ming; Wu, Tzu Chin; Chen, Hung Jen; Chen, Hsuan Yu; Chang, Chi Sheng; Hsu, Chung Ping; Hsia, Jiun Yi; Chuang, Cheng Yen; Lin, Chin Hung; Chen, Jeremy J.W.; Chen, Kuan Yu; Liao, Wei Yu; Shih, Jin Yuan; Yu, Sung Liang; Yu, Chong Jen; Yang, Pan Chyr; Yang, Tsung Ying; Chang, Gee Chen.

In: Carcinogenesis, Vol. 37, No. 2, 08.09.2015, p. 157-162.

Research output: Contribution to journalArticle

Tseng, CH, Chen, KC, Hsu, KH, Tseng, JS, Ho, CC, Hsia, TC, Su, KY, Wu, MF, Chiu, KL, Liu, CM, Wu, TC, Chen, HJ, Chen, HY, Chang, CS, Hsu, CP, Hsia, JY, Chuang, CY, Lin, CH, Chen, JJW, Chen, KY, Liao, WY, Shih, JY, Yu, SL, Yu, CJ, Yang, PC, Yang, TY & Chang, GC 2015, 'EGFR mutation and lobar location of lung adenocarcinoma', Carcinogenesis, vol. 37, no. 2, pp. 157-162. https://doi.org/10.1093/carcin/bgv168
Tseng CH, Chen KC, Hsu KH, Tseng JS, Ho CC, Hsia TC et al. EGFR mutation and lobar location of lung adenocarcinoma. Carcinogenesis. 2015 Sep 8;37(2):157-162. https://doi.org/10.1093/carcin/bgv168
Tseng, Chien Hua ; Chen, Kun Chieh ; Hsu, Kuo Hsuan ; Tseng, Jeng Sen ; Ho, Chao Chi ; Hsia, Te Chun ; Su, Kang Yi ; Wu, Ming Fang ; Chiu, Kuo Liang ; Liu, Chien Ming ; Wu, Tzu Chin ; Chen, Hung Jen ; Chen, Hsuan Yu ; Chang, Chi Sheng ; Hsu, Chung Ping ; Hsia, Jiun Yi ; Chuang, Cheng Yen ; Lin, Chin Hung ; Chen, Jeremy J.W. ; Chen, Kuan Yu ; Liao, Wei Yu ; Shih, Jin Yuan ; Yu, Sung Liang ; Yu, Chong Jen ; Yang, Pan Chyr ; Yang, Tsung Ying ; Chang, Gee Chen. / EGFR mutation and lobar location of lung adenocarcinoma. In: Carcinogenesis. 2015 ; Vol. 37, No. 2. pp. 157-162.
@article{e72148ebcba6410486f56080dece787d,
title = "EGFR mutation and lobar location of lung adenocarcinoma",
abstract = "The objective of this study was to investigate the associations among lung cancer location, and epidermal growth factor receptor (EGFR) mutation status. Treatment-naive, pathologically confirmed lung adenocarcinomas with tumor specimens available for genetic analysis were included from 2011 through 2014. Overall, 1771 patients with lung adenocarcinoma were included for analysis, after excluding those with carcinoma not otherwise specified, or synchronous multiple primary lung cancers. The median age was 64 years, and the female:male and never smoker:ever smoker ratios were 930:855 (52:48{\%}) and 1167:604 (65:35{\%}), respectively. The EGFR mutation rate was 56{\%}. Among patients, 1093 (62{\%}) had primary tumors in the upper lobes. Compared with the characteristics of the EGFR wild-type, tumors with EGFR activating mutations were more common in women (P < 0.001), never smokers (P < 0.001), and in the upper lobes (P = 0.004). Among EGFR activating mutations, compared with the EGFR exon 19 deletion, L858R mutation were more common in women (P = 0.002), never smokers (P = 0.038), and the upper lobes P < 0.0005). The present study is the first to address that different pulmonary lobar locations might harbor different EGFR mutation subtypes. We demonstrated that adenocarcinomas with L858R mutation, rather than exon 19 deletion or wild-type EGFR gene, prefer to locate over the upper lungs. This phenomenon was more significant in females and never-smokers, implying the result of complex interactions between genetic susceptibility and environmental factors. Therefore, EGFR L858R mutation and exon 19 deletion may not be identical disease entity from the point of carcinogenesis.",
author = "Tseng, {Chien Hua} and Chen, {Kun Chieh} and Hsu, {Kuo Hsuan} and Tseng, {Jeng Sen} and Ho, {Chao Chi} and Hsia, {Te Chun} and Su, {Kang Yi} and Wu, {Ming Fang} and Chiu, {Kuo Liang} and Liu, {Chien Ming} and Wu, {Tzu Chin} and Chen, {Hung Jen} and Chen, {Hsuan Yu} and Chang, {Chi Sheng} and Hsu, {Chung Ping} and Hsia, {Jiun Yi} and Chuang, {Cheng Yen} and Lin, {Chin Hung} and Chen, {Jeremy J.W.} and Chen, {Kuan Yu} and Liao, {Wei Yu} and Shih, {Jin Yuan} and Yu, {Sung Liang} and Yu, {Chong Jen} and Yang, {Pan Chyr} and Yang, {Tsung Ying} and Chang, {Gee Chen}",
year = "2015",
month = "9",
day = "8",
doi = "10.1093/carcin/bgv168",
language = "English",
volume = "37",
pages = "157--162",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - EGFR mutation and lobar location of lung adenocarcinoma

AU - Tseng, Chien Hua

AU - Chen, Kun Chieh

AU - Hsu, Kuo Hsuan

AU - Tseng, Jeng Sen

AU - Ho, Chao Chi

AU - Hsia, Te Chun

AU - Su, Kang Yi

AU - Wu, Ming Fang

AU - Chiu, Kuo Liang

AU - Liu, Chien Ming

AU - Wu, Tzu Chin

AU - Chen, Hung Jen

AU - Chen, Hsuan Yu

AU - Chang, Chi Sheng

AU - Hsu, Chung Ping

AU - Hsia, Jiun Yi

AU - Chuang, Cheng Yen

AU - Lin, Chin Hung

AU - Chen, Jeremy J.W.

AU - Chen, Kuan Yu

AU - Liao, Wei Yu

AU - Shih, Jin Yuan

AU - Yu, Sung Liang

AU - Yu, Chong Jen

AU - Yang, Pan Chyr

AU - Yang, Tsung Ying

AU - Chang, Gee Chen

PY - 2015/9/8

Y1 - 2015/9/8

N2 - The objective of this study was to investigate the associations among lung cancer location, and epidermal growth factor receptor (EGFR) mutation status. Treatment-naive, pathologically confirmed lung adenocarcinomas with tumor specimens available for genetic analysis were included from 2011 through 2014. Overall, 1771 patients with lung adenocarcinoma were included for analysis, after excluding those with carcinoma not otherwise specified, or synchronous multiple primary lung cancers. The median age was 64 years, and the female:male and never smoker:ever smoker ratios were 930:855 (52:48%) and 1167:604 (65:35%), respectively. The EGFR mutation rate was 56%. Among patients, 1093 (62%) had primary tumors in the upper lobes. Compared with the characteristics of the EGFR wild-type, tumors with EGFR activating mutations were more common in women (P < 0.001), never smokers (P < 0.001), and in the upper lobes (P = 0.004). Among EGFR activating mutations, compared with the EGFR exon 19 deletion, L858R mutation were more common in women (P = 0.002), never smokers (P = 0.038), and the upper lobes P < 0.0005). The present study is the first to address that different pulmonary lobar locations might harbor different EGFR mutation subtypes. We demonstrated that adenocarcinomas with L858R mutation, rather than exon 19 deletion or wild-type EGFR gene, prefer to locate over the upper lungs. This phenomenon was more significant in females and never-smokers, implying the result of complex interactions between genetic susceptibility and environmental factors. Therefore, EGFR L858R mutation and exon 19 deletion may not be identical disease entity from the point of carcinogenesis.

AB - The objective of this study was to investigate the associations among lung cancer location, and epidermal growth factor receptor (EGFR) mutation status. Treatment-naive, pathologically confirmed lung adenocarcinomas with tumor specimens available for genetic analysis were included from 2011 through 2014. Overall, 1771 patients with lung adenocarcinoma were included for analysis, after excluding those with carcinoma not otherwise specified, or synchronous multiple primary lung cancers. The median age was 64 years, and the female:male and never smoker:ever smoker ratios were 930:855 (52:48%) and 1167:604 (65:35%), respectively. The EGFR mutation rate was 56%. Among patients, 1093 (62%) had primary tumors in the upper lobes. Compared with the characteristics of the EGFR wild-type, tumors with EGFR activating mutations were more common in women (P < 0.001), never smokers (P < 0.001), and in the upper lobes (P = 0.004). Among EGFR activating mutations, compared with the EGFR exon 19 deletion, L858R mutation were more common in women (P = 0.002), never smokers (P = 0.038), and the upper lobes P < 0.0005). The present study is the first to address that different pulmonary lobar locations might harbor different EGFR mutation subtypes. We demonstrated that adenocarcinomas with L858R mutation, rather than exon 19 deletion or wild-type EGFR gene, prefer to locate over the upper lungs. This phenomenon was more significant in females and never-smokers, implying the result of complex interactions between genetic susceptibility and environmental factors. Therefore, EGFR L858R mutation and exon 19 deletion may not be identical disease entity from the point of carcinogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84962040543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962040543&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgv168

DO - 10.1093/carcin/bgv168

M3 - Article

C2 - 26645716

AN - SCOPUS:84962040543

VL - 37

SP - 157

EP - 162

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 2

ER -